Vigil Neuroscience Inc (VIGL)
3.03
+0.29
(+10.58%)
USD |
NASDAQ |
May 03, 16:00
2.96
-0.07
(-2.31%)
After-Hours: 20:00
Vigil Neuroscience Price to Book Value: 0.9614 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 0.9614 |
| May 02, 2024 | 0.8694 |
| May 01, 2024 | 0.8408 |
| April 30, 2024 | 0.8281 |
| April 29, 2024 | 0.8249 |
| April 26, 2024 | 0.8598 |
| April 25, 2024 | 0.8186 |
| April 24, 2024 | 0.8789 |
| April 23, 2024 | 0.8408 |
| April 22, 2024 | 0.9011 |
| April 19, 2024 | 0.8947 |
| April 18, 2024 | 0.8725 |
| April 17, 2024 | 0.9265 |
| April 16, 2024 | 0.9614 |
| April 15, 2024 | 1.003 |
| April 12, 2024 | 1.022 |
| April 11, 2024 | 1.041 |
| April 10, 2024 | 1.012 |
| April 09, 2024 | 1.050 |
| April 08, 2024 | 1.104 |
| April 05, 2024 | 1.057 |
| April 04, 2024 | 1.034 |
| April 03, 2024 | 1.031 |
| April 02, 2024 | 1.055 |
| April 01, 2024 | 1.044 |
| Date | Value |
|---|---|
| March 28, 2024 | 1.082 |
| March 27, 2024 | 1.015 |
| March 26, 2024 | 0.8852 |
| March 25, 2024 | 0.9518 |
| March 22, 2024 | 0.9074 |
| March 21, 2024 | 0.9645 |
| March 20, 2024 | 1.018 |
| March 19, 2024 | 0.9328 |
| March 18, 2024 | 0.9963 |
| March 15, 2024 | 1.063 |
| March 14, 2024 | 0.8757 |
| March 13, 2024 | 0.9201 |
| March 12, 2024 | 0.9455 |
| March 11, 2024 | 1.006 |
| March 08, 2024 | 1.028 |
| March 07, 2024 | 1.076 |
| March 06, 2024 | 1.003 |
| March 05, 2024 | 1.031 |
| March 04, 2024 | 1.012 |
| March 01, 2024 | 1.076 |
| February 29, 2024 | 1.104 |
| February 28, 2024 | 1.065 |
| February 27, 2024 | 1.043 |
| February 26, 2024 | 1.025 |
| February 23, 2024 | 0.9662 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3793
Minimum
May 12 2022
2.762
Maximum
Oct 28 2022
1.524
Average
1.573
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.094 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7539 |
| Theriva Biologics Inc | 0.187 |
| Oragenics Inc | 3.043 |
Price to Book Value Related Metrics
| Price | 3.03 |
| Earnings Yield | -70.30% |
| Market Cap | 111.76M |